美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

美國抗疫概念

1,375.27

+19.551.44%

漲家數：17

跌家數：2

平家數：1

市盈率：- -

高：1,386.07

開：1,359.33

低：1,359.33

收：1,355.71

資料載入中...

Nanoviricides, Inc.盤中異動股價大漲5.19%報1.42美元

吉利德科學盤中異動早盤股價大跌3.41%

Equillium, Inc.盤中異動股價大跌5.96%

吉利德科學(GILD)第一季同比扭虧為盈至13.15億美元

輝瑞英立達獲批國內首個且唯一晚期腎癌一線靶免聯合治療

輝瑞：阿昔替尼獲批中國首個且唯一晚期腎癌一線靶免聯合治療

港股異動 | 和鉑醫藥-B(02142)再漲超4% 公司與阿斯利康合作深化已與多家MNC達成合作協議

和鉑醫藥再漲超4%公司與阿斯利康合作深化已與多家MNC達成合作協議

諾瓦瓦克斯新冠疫苗獲批？錯過截止日期後反轉了！

生物制品圈

輝瑞4月24日成交額為7.94億美元

莫德納4月24日成交額為1.29億美元

強生4月24日成交額為12.84億美元

吉利德科學4月24日成交額為10.79億美元

雅培4月24日成交額為8.54億美元

吉利德科學首季扭虧為盈維持年度業績預測

BUZZ-季度銷售額低於預期，吉利德科學公司業績下滑

Biontech Se盤中異動快速上漲5.02%報120.60美元

Vir Biotechnology, Inc.盤中異動快速上漲5.03%報6.27美元

健康巡講：接觸細菌毒素可能是結腸癌發病年齡提前的原因

Alpha Pro Tech, Ltd.盤中異動下午盤快速拉昇5.31%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4568/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美國抗疫概念","latestPrice":1375.2667,"timestamp":1746215999999,"preClose":1355.7122,"halted":0,"volume":90281388,"delay":0,"changeRate":0.014424,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":19.554565,"latestTime":"05-02 16:00:00 EDT","open":1359.3263,"high":1386.07,"low":1359.3263,"amount":4683518595.783152,"amplitude":0.019727,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.677286,"peRate":21.976197,"turnoverRate":0.005819,"increases":17,"decrements":2,"flats":1,"marketCap":1136531230970,"floatMarketCap":1116501984572.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1386.07,"amplitude":0.019727,"preClose":1355.7122,"low":1359.3263,"pbRate":"3.677286","latestPrice":1375.2667,"volume":90281388,"delay":0,"open":1359.3263,"prevYearClose":1274.8187,"prevWeekClose":1341.1263,"prevMonthClose":1374.5028,"prevQuarterClose":1427.887,"fiveDayClose":1341.1263,"twentyDayClose":1401.546,"sixtyDayClose":1373.9138,"secType":"PLATE","market":"US","turnoverRate":0.005819,"peRate":21.976197,"marketCap":1136531230970,"floatMarketCap":1116501984572.5,"timestamp":1746215999999,"nameCN":"美國抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":17,"down":2,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530702132","title":"Nanoviricides, Inc.盤中異動 股價大漲5.19%報1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530702132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530702132?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 22:19","pubTimestamp":1745590784,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日22时19分，Nanoviricides, Inc.股票出现异动，股价快速上涨5.19%。截至发稿，该股报1.42美元/股，成交量4.7281万股，换手率0.30%，振幅2.89%。Nanoviricides, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Nanoviricides, Inc.公司简介：Nanoviricides Inc是一家纳米生物制药公司，致力于发现、开发和商业化治疗剂，以推进对患有危及生命的病毒感染患者的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425221944aa2c7bb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425221944aa2c7bb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","NNVC"],"gpt_icon":0},{"id":"2530139608","title":"吉利德科學盤中異動 早盤股價大跌3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530139608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530139608?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 21:31","pubTimestamp":1745587905,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时31分，吉利德科学股票出现波动，股价快速下挫3.41%。吉利德科学股票所在的制药行业中，整体跌幅为0.18%。消息层面，截至21时31分，《吉利德科学首季扭亏为盈维持年度业绩预测》资讯为影响吉利德科学的重要信息。该信息摘要如下：吉利德科学在2023年第一季度实现了扭亏为盈，营收达67亿美元，净利润为13.15亿美元，优于市场预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213145a6c81d0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213145a6c81d0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0234570918.USD","LU2089984988.USD","LU0320765992.SGD","BK4532","LU0289739699.SGD","GILD","BK4583","LU1430594728.SGD","BK4568","LU0109394709.USD","LU1839511570.USD","LU1066051498.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","IE0002270589.USD","IE00B3T34201.USD","IE00B7SZLL34.SGD","BK4578","LU1585245621.USD","BK4588","BK4566","IE00BSNM7G36.USD","LU1066053197.SGD","LU0889565916.HKD","LU1571399168.USD","IE00B19Z3581.USD","BK4139","BK4585","IE00BKVL7J92.USD","LU2468319806.SGD","IE00B19Z3B42.SGD","BK4550"],"gpt_icon":0},{"id":"2530139775","title":"Equillium, Inc.盤中異動 股價大跌5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530139775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530139775?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 21:31","pubTimestamp":1745587896,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时31分，Equillium, Inc.股票出现异动，股价快速跳水5.96%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213136a6c81cfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213136a6c81cfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2530990724","title":"吉利德科學(GILD)第一季同比扭虧為盈至13.15億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530990724","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530990724?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 18:15","pubTimestamp":1745576112,"startTime":"0","endTime":"0","summary":"金吾财讯 | 吉利德科学(GILD)公布首季财报，按年扭亏为盈，录季度纯利13.15亿美元，对上财年同季录亏损41.7亿美元，主要涉及研发减值24.3亿美元及收购正进行研发所涉开支41.31亿美元拖累。季度每股摊薄纯利1.04美元，经调整后为1.81美元，略高于市场预期的1.79美元。季度收入按年跌不足1%至66.67亿美元，市场预期为68亿美元。公司爱滋病药Biktarvy销售按年升7%至31.5亿美元，符合市场预期。肝病药销售按年升3%至7.58亿美元。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/YTEwMTc4Njg5ODk4OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YTEwMTc4Njg5ODk4OA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"287876","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU0109394709.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4583","IE00B7SZLL34.SGD","LU2468319806.SGD","BK4585","BK4139","BK4550","IE00BSNM7G36.USD","LU0058720904.USD","BK4588","LU0289739699.SGD","LU1571399168.USD","LU2087621335.USD","BK4566","BK4568","LU1430594728.SGD","LU1585245621.USD","LU2089984988.USD","IE00BKVL7J92.USD","LU0320765992.SGD","BK4578","IE00B19Z3581.USD","GILD","LU0234570918.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","BK4532","LU0889565916.HKD","LU1839511570.USD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2530905116","title":"輝瑞英立達 獲批國內首個且唯一晚期腎癌一線靶免聯合治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2530905116","media":"21经济网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530905116?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 16:57","pubTimestamp":1745571434,"startTime":"0","endTime":"0","summary":"南方财经4月25日电，辉瑞公司今日宣布，其口服靶向药英立达?（Inlyta?，通用名：阿昔替尼片）于2025年4月22日获得国家药品监督管理局（NMPA）批准，联合特瑞普利单抗用于中高危的不可切除或转移性肾细胞癌（RCC）患者的一线治疗，这也是中国肾癌治疗领域首个且唯一获批的一线靶免联合治疗方案。（21世纪经济报道）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171322a6c7d0d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171322a6c7d0d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999011175.SGD","LU0306807586.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1894683348.USD","BK4585","BK4592","BK4007","IE000M9KFDE8.USD","SG9999002224.SGD","BK4568","IE00BLSP4452.SGD","LU0058720904.USD","LU0122379950.USD","BK4581","LU0225284248.USD","LU0985481810.HKD","BK4550","BK4534","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1883839398.USD","LU1066051498.USD","LU0321505868.SGD","IE00BBT3K403.USD","SG9999001176.USD","LU0234572021.USD","SG9999001176.SGD","LU0306806265.USD","SG9999002232.USD","LU1894683264.USD","BK4599","IE0002270589.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0170899867.USD","LU0225771236.USD","LU1023059063.AUD","SG9999003800.SGD","BK4533","LU0289739699.SGD","SGXZ57979304.SGD","LU0868494617.USD","BK4588","PFE","LU0456855351.SGD","LU0321505439.SGD"],"gpt_icon":0},{"id":"2530970288","title":"輝瑞：阿昔替尼獲批中國首個且唯一晚期腎癌一線靶免聯合治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2530970288","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530970288?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 16:55","pubTimestamp":1745571304,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0456855351.SGD","LU0306807586.USD","LU1066051498.USD","LU0985481810.HKD","SG9999011175.SGD","IE00BLSP4452.SGD","BK4585","BK4599","LU1894683264.USD","LU1057294990.SGD","SG9999001176.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","LU1894683348.USD","BK4581","BK4533","BK4534","BK4588","LU0306806265.USD","IE00B19Z3B42.SGD","LU1883839398.USD","SG9999001176.SGD","BK4007","LU0225284248.USD","RCC","LU0868494617.USD","IE00B19Z3581.USD","SG9999013999.USD","IE000M9KFDE8.USD","BK4550","IE00BLSP4239.USD","IE0002270589.USD","LU0225771236.USD","LU1066053197.SGD","LU0321505439.SGD","LU0234572021.USD","SG9999002224.SGD","LU0170899867.USD","LU0289739699.SGD","BK4568","SG9999003800.SGD","LU1023059063.AUD","LU0122379950.USD","PFE","BK4592","SG9999002232.USD","LU0321505868.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2530924793","title":"港股異動 | 和鉑醫藥-B(02142)再漲超4% 公司與阿斯利康合作深化 已與多家MNC達成合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2530924793","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530924793?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 14:27","pubTimestamp":1745562446,"startTime":"0","endTime":"0","summary":"消息面上，和铂医药3月发布公告称，与阿斯利康订立全球战略合作协议，共同研发针对免疫性疾病、肿瘤及其他多种疾病的新一代多特异性抗体。太平洋证券指出，和铂医药已多次获得阿斯利康的青睐。和铂医药凭借3次合作，以及此次超45亿美元的潜在总交易金额，稳居阿斯利康中国BD交易榜首。除了阿斯利康之外，和铂医药还曾与辉瑞、艾伯维等多家MNC达成合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","LU0320765992.SGD","BK4007","02142","LU0109394709.USD","LU2236285917.USD","BK1161","LU1829250122.USD","LU2417539215.USD","BK4588","LU0889565916.HKD","BK1583","AZN","BK4568","LU2456880835.USD","LU2462157665.USD","BK1574"],"gpt_icon":0},{"id":"2530927861","title":"和鉑醫藥再漲超4%公司與阿斯利康合作深化已與多家MNC達成合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2530927861","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530927861?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 14:27","pubTimestamp":1745562420,"startTime":"0","endTime":"0","summary":"和铂医药与阿斯利康深化合作，共建创新中心，并获得多家跨国药企青睐，凭借其专有技术平台不断发展。股价再涨超4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042514344894e20e10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042514344894e20e10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU2417539215.USD","BK4568","LU2456880835.USD","LU1829250122.USD","BK4585","AZN","BK4007","LU2236285917.USD","LU0320765992.SGD","LU2462157665.USD","BK4588","LU0889565916.HKD","02142"],"gpt_icon":0},{"id":"2530186200","title":"諾瓦瓦克斯新冠疫苗獲批？錯過截止日期後反轉了！","url":"https://stock-news.laohu8.com/highlight/detail?id=2530186200","media":"生物制品圈","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530186200?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 11:17","pubTimestamp":1745551038,"startTime":"0","endTime":"0","summary":"诺瓦瓦克斯公司也很 “上道”，在新闻稿里拍着胸脯保证，会 “光速” 处理FDA 的要求，快马加鞭推动这款候选疫苗获批，争取早日 “通关”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425172937a4669a42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425172937a4669a42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4547","CDC","NVAX","BK4585","BK4588","BK4139"],"gpt_icon":1},{"id":"2530911943","title":"輝瑞4月24日成交額為7.94億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530911943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530911943?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 10:18","pubTimestamp":1745547492,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，辉瑞成交额为7.94亿美元，成交额较昨日减少30.67%，当日成交量为3500.96万股。辉瑞于2025年4月24日涨1.74%，报22.78美元，该股过去5个交易日涨3.36%，年初至今跌12.71%，过去60日跌14.84%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-24|7.94亿|-30.67%|3500.96万|#|2025-04-23|11.45亿|41.51%|5078.10万|#|2025-04-22|8.09亿|14.76%|3605.26万|#|2025-04-21|7.05亿|-41.56%|3202.10万|#|2025-04-17|12.06亿|44.24%|5407.37万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425101820a4662ad2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425101820a4662ad2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999003800.SGD","SG9999001176.SGD","LU0225771236.USD","LU0058720904.USD","LU1023059063.AUD","BK4533","LU0985481810.HKD","PFE","SG9999002232.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4007","BK4550","BK4588","LU0321505868.SGD","LU0306807586.USD","IE00BBT3K403.USD","LU0321505439.SGD","LU0234572021.USD","SG9999001176.USD","BK4585","BK4592","BK4568","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","SGXZ57979304.SGD","SG9999013999.USD","LU0868494617.USD","LU1883839398.USD","LU1894683264.USD","BK4534","IE000M9KFDE8.USD","BK4581","LU0456855351.SGD","BK4599","SG9999011175.SGD","LU0170899867.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU0225284248.USD","LU0306806265.USD","LU1057294990.SGD","IE0002270589.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"2530943609","title":"莫德納4月24日成交額為1.29億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530943609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530943609?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 10:01","pubTimestamp":1745546491,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，莫德纳成交额为1.29亿美元，成交额较昨日减少40.25%，当日成交量为479.49万股。莫德纳于2025年4月24日涨3.2%，报27.39美元，该股过去5个交易日涨8.73%，年初至今跌34.13%，过去60日跌39.05%。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证，该疫苗于 2020 年 12 月在美国获得批准。截至 2024年9月，莫德纳拥有处于临床试验中的40个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425100140a6c763ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425100140a6c763ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRNA","BK4534","BK4532","BK4548","BK4551","BK4533","BK4588","BK4501","BK4568","BK4585"],"gpt_icon":1},{"id":"2530488179","title":"強生4月24日成交額為12.84億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530488179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530488179?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 09:45","pubTimestamp":1745545546,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，强生成交额为12.84亿美元，成交额较昨日减少9.23%，当日成交量为831.04万股。强生于2025年4月24日跌0.29%，报154.93美元，该股过去5个交易日涨0.66%，年初至今涨7.98%，过去60日涨3.85%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-24|12.84亿|-9.23%|831.04万|#|2025-04-23|14.15亿|25.78%|909.94万|#|2025-04-22|11.25亿|14.06%|713.63万|#|2025-04-21|9.86亿|-42.98%|628.54万|#|2025-04-17|17.30亿|40.68%|1098.11万|强生公司是世界上最大的、最多元化的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425094553a6c75f02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425094553a6c75f02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2089984988.USD","LU0889566641.SGD","IE000M9KFDE8.USD","LU1023059063.AUD","LU1261432733.SGD","IE00BJT1NW94.SGD","JNJ","IE0034235303.USD","IE00B7SZLL34.SGD","LU2430703178.SGD","IE00B2B36J28.USD","LU2505996681.GBP","LU2112291526.USD","LU0345770308.USD","LU0882574055.USD","LU2468319806.SGD","BK4007","LU1674673428.USD","IE00BLSP4452.SGD","LU1074936037.SGD","BK4559","SG9999002232.USD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU2129689605.HKD","LU1221951129.SGD","LU0792757196.USD","LU1032955483.USD","BK4534","BK4568","LU1929549753.HKD","LU1244550221.USD","LU1674673691.USD","IE00BDGV0183.EUR","LU0640476718.USD","LU1732799900.SGD","LU2505996509.AUD","LU1057294990.SGD","SG9999001440.SGD","LU0234572021.USD","LU0114720955.EUR","LU2602419157.SGD","LU0289739699.SGD","LU1196500208.SGD","LU2129689514.USD","LU1059921491.USD","LU2129689431.USD","BK4581","BK4532","LU0985320562.USD"],"gpt_icon":0},{"id":"2530910008","title":"吉利德科學4月24日成交額為10.79億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530910008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530910008?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 09:34","pubTimestamp":1745544851,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，吉利德科学成交额为10.79亿美元，成交额较昨日增加24.42%，当日成交量为1013.32万股。吉利德科学于2025年4月24日跌0.22%，报106.15美元，该股过去5个交易日涨1.21%，年初至今涨15.73%，过去60日涨13.9%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425093414a4661d30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425093414a4661d30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4566","BK4583","BK4532","LU2089984988.USD","IE00BKVL7J92.USD","LU1430594728.SGD","BK4585","LU1839511570.USD","LU2468319806.SGD","BK4139","LU1066051498.USD","IE00B19Z3B42.SGD","LU0058720904.USD","IE0002270589.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","BK4568","LU0320765992.SGD","IE00B19Z3581.USD","BK4578","LU1066053197.SGD","LU0889565916.HKD","LU1571399168.USD","LU0234570918.USD","LU0289739699.SGD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","GILD","IE00B3T34201.USD","LU0109394709.USD","LU2087621335.USD","BK4588","BK4550"],"gpt_icon":0},{"id":"2530914084","title":"雅培4月24日成交額為8.54億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530914084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530914084?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 09:15","pubTimestamp":1745543714,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，雅培成交额为8.54亿美元，成交额较昨日减少24.89%，当日成交量为659.55万股。雅培于2025年4月24日跌0.35%，报129.38美元，该股过去5个交易日跌0.25%，年初至今涨15.51%，过去60日涨2.03%。雅培约 60% 的销售额来自美国以外地区。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425091524a46616a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425091524a46616a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4504","IE00BFTCPJ56.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU1721429402.USD","LU1023059063.AUD","SG9999002232.USD","BK4568","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0234572021.USD","BK4581","BK4585","LU0868494617.USD","LU1721429741.USD","LU1989763690.USD","BK4588","LU2237957902.USD","LU0122379950.USD","SGXZ23171101.USD","LU2133065610.SGD","IE00BJJMRZ35.SGD","SG9999002224.SGD","LU2468319806.SGD","IE0002141913.USD","LU2112291526.USD","BK4533","IE00B2B36J28.USD","LU0266013472.USD","SG9999004303.SGD","ABT","BK4566","LU2089984988.USD","LU1989763427.SGD","BK4592","LU1691799644.USD","IE0009355771.USD","LU0170899867.USD","LU2237957811.SGD","LU1914381329.SGD","BK4082"],"gpt_icon":0},{"id":"2530142289","title":"吉利德科學首季扭虧為盈維持年度業績預測","url":"https://stock-news.laohu8.com/highlight/detail?id=2530142289","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530142289?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 09:07","pubTimestamp":1745543220,"startTime":"0","endTime":"0","summary":"吉利德科学在2023年第一季度实现了扭亏为盈，营收达67亿美元，净利润为13.15亿美元，优于市场预期。去年同期因撇账亏损41.7亿美元。调整后每股盈利1.81美元，略高于市场预期的1.79美元。公司维持年度业绩预测不变，预计全年收入在282亿至286亿美元之间，调整后每股盈利在7.7至8.1美元之间。这些预测已经考虑了美国总统特朗普关税政策的影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042509114894e1b5f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042509114894e1b5f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4585","LU1585245621.USD","LU1571399168.USD","IE00B19Z3B42.SGD","BK4566","IE00B3T34201.USD","IE00B7SZLL34.SGD","BK4588","BK4532","LU2468319806.SGD","LU1430594728.SGD","LU2089984988.USD","LU1839511570.USD","LU0109394709.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4568","IE0002270589.USD","BK4550","LU2087621335.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","BK4583","LU1066053197.SGD","LU0289739699.SGD","GILD","BK4139","BK4578","LU0320765992.SGD","LU1066051498.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2530998469","title":"BUZZ-季度銷售額低於預期，吉利德科學公司業績下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2530998469","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530998469?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 04:20","pubTimestamp":1745526025,"startTime":"0","endTime":"0","summary":"4月24日 -  ** 制药商吉利德科学公司GILD.O股价在延时交易中下跌3.4%，至102.59美元。** 公司抗癌药物 Trodelvy 的销售额下降 5%，至 2.93 亿美元 ** 公司的 COVID-19 抗病毒药物 Veklury 销售额下降 45%，至 3.02 亿美元。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL4T3R2280:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU1066051498.USD","BK4583","LU0320765992.SGD","LU0058720904.USD","GILD","IE00B3T34201.USD","LU0889565916.HKD","LU1585245621.USD","LU2087621335.USD","BK4566","BK4568","BK4578","BK4588","IE0002270589.USD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","BK4532","LU1430594728.SGD","LU2089984988.USD","LU0289739699.SGD","LU1571399168.USD","IE00BSNM7G36.USD","LU1839511570.USD","LU1066053197.SGD","BK4585","IE00B19Z3B42.SGD","BK4139","IE00B7SZLL34.SGD","BK4550","LU0109394709.USD","LU2468319806.SGD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2530840960","title":"Biontech Se盤中異動 快速上漲5.02%報120.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530840960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530840960?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 04:00","pubTimestamp":1745524859,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日04时00分，Biontech Se股票出现波动，股价大幅上涨5.02%。截至发稿，该股报120.60美元/股，成交量139.992万股，换手率0.58%，振幅5.86%。Biontech Se股票所在的生物技术行业中，整体涨幅为0.80%。Biontech Se公司简介：BioNTech是一家总部位于德国的生物技术公司，专注于开发癌症治疗药物，包括个体化免疫疗法，以及包括冠状病毒在内的传染病疫苗。BioNTech与几家大型制药公司合作，包括罗氏、礼来、辉瑞、赛诺菲和Genmab。冠状病毒疫苗是其首个商业化产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504250400599743fe53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504250400599743fe53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BNTX","BK4548","BK4139","BK4551","BK4585","BK4588","BK4535"],"gpt_icon":0},{"id":"2530716967","title":"Vir Biotechnology, Inc.盤中異動 快速上漲5.03%報6.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530716967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530716967?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 03:53","pubTimestamp":1745524415,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日03时53分，Vir Biotechnology, Inc.股票出现异动，股价大幅上涨5.03%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042503533794e16e22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042503533794e16e22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","VIR","BK4585","BK4535","BK4139"],"gpt_icon":0},{"id":"2530096489","title":"健康巡講：接觸細菌毒素可能是結腸癌發病年齡提前的原因","url":"https://stock-news.laohu8.com/highlight/detail?id=2530096489","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530096489?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 03:08","pubTimestamp":1745521705,"startTime":"0","endTime":"0","summary":"今天，我们将介绍一项研究，该研究可能揭示了年轻人结肠癌发病率上升这一令人担忧的趋势背后的原因。儿童期肠道细菌可解释早发结肠癌 一项新的研究表明，儿童时期接触结肠中的一种细菌毒素可能会引发年轻患者结肠直肠癌病例的增加。两组的不良事件发生率相似。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL4S3R2243:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0456855351.SGD","LU0985481810.HKD","BK4007","SG9999013999.USD","IE00BLSP4239.USD","BK4581","LU0234572021.USD","LU1894683348.USD","BK4592","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","LU0170899867.USD","IE00B19Z3581.USD","LU0225284248.USD","LU0321505439.SGD","SG9999002224.SGD","LU0321505868.SGD","LU1066051498.USD","LU1023059063.AUD","BK4533","SG9999001176.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0289739699.SGD","LU0868494617.USD","LU0058720904.USD","IE0002270589.USD","LU0306807586.USD","BK4588","LU0225771236.USD","BK4568","IE000M9KFDE8.USD","SG9999001176.SGD","BK4550","BK4599","LU1066053197.SGD","SG9999002232.USD","LU0122379950.USD","LU1883839398.USD","LU1057294990.SGD","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2530962110","title":"Alpha Pro Tech, Ltd.盤中異動 下午盤快速拉昇5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530962110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530962110?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 02:38","pubTimestamp":1745519913,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日02时38分，Alpha Pro Tech, Ltd.股票出现波动，股价大幅拉升5.31%。截至发稿，该股报4.56美元/股，成交量2.0343万股，换手率0.19%，振幅4.04%。Alpha Pro Tech, Ltd.股票所在的建筑设备行业中，整体涨幅为1.55%。Alpha Pro Tech, Ltd.公司简介：Alpha Pro Tech Ltd从事保护人员、产品和环境的业务。它还生产一系列建筑耐候产品，这些产品以Alpha Pro Tech品牌销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425023833a465bd3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425023833a465bd3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APT","BK4568","BK4086"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":6,"totalSize":178,"code":"91000000","status":"200"}]}}